ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 5,562 | 10,034 | 5,036 | 5,187 | 114 |
| Cost of Goods | 2,408 | 4,726 | 2,322 | 2,119 | N/A |
| Gross Profit | 3,154 | 5,308 | 2,714 | 3,068 | 114 |
| Operating Expenses | 3,159 | -477 | 3,243 | 2,600 | 7,046 |
| Operating Income | 403 | 6,511 | -207 | 586 | -6,932 |
| Interest Expense | 93 | 621 | 81 | 501 | 124 |
| Other Income | -50 | 3,109 | -91 | -50 | -3,208 |
| Pre-tax Income | 260 | 8,999 | -380 | 35 | -10,265 |
| Income Tax | N/A | -35 | -1 | N/A | N/A |
| Net Income Continuous | 260 | 9,034 | -379 | 35 | -10,265 |
| Net Income Discontinuous | N/A | 66 | 2 | 0 | N/A |
| Net Income | $260 | $9,100 | $-377 | $35 | $-10,265 |
| EPS Basic Total Ops | 0.00 | N/A | -1,295.10 | -1,644.86 | -3.18 |
| EPS Basic Continuous Ops | N/A | N/A | -1,295.82 | -1,644.86 | -3.18 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.72 | 0.00 | N/A |
| EPS Diluted Total Ops | 0.00 | N/A | -1,295.10 | -1,644.86 | -3.18 |
| EPS Diluted Continuous Ops | N/A | N/A | -1,295.82 | -1,644.86 | -3.18 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.72 | 0.00 | N/A |
| EBITDA(a) | $548 | $6,653 | $-63 | $837 | $-6,901 |